Discovery of novel 6-hydroxybenzothiazole urea derivatives as dual Dyrk1A/α-synuclein aggregation inhibitors with neuroprotective effects-Reference-Cited by-同舟云学术

Discovery of novel 6-hydroxybenzothiazole urea derivatives as dual Dyrk1A/α-synuclein aggregation inhibitors with neuroprotective effects

Published:2022-01 Issue: Volume:227 Page:113911
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

AlNajjar Yasmeen T.,Gabr Moustafa^ORCID,ElHady Ahmed K.,Salah Mohamed^ORCID,Wilms Gerrit^ORCID,Abadi Ashraf H.,Becker Walter^ORCID,Abdel-Halim Mohammad^ORCID,Engel Matthias

Funder

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference80 articles.

1. DYRK1A: a down syndrome-related dual protein kinase with a versatile role in tumorigenesis;Laham;Cell. Mol. Life Sci.,2020

2. Biological characterization of 8-cyclopropyl-2-(Pyridin-3-yl)thiazolo[5,4-f]quinazolin-9(8h)-one, a promising inhibitor of DYRK1A;Fruit;Pharmaceuticals,2019

3. Identification and characterization of bi-thiazole-2,2′-diamines as kinase inhibitory scaffolds;Ngoei;Biochim. Biophys. Acta Protein Proteonomics,2013

4. The protein interaction landscape of the human CMGC kinase group;Varjosalo;Cell Rep.,2013

5. Structures of down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition;Soundararajan;Structure,2013

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review on synthetic inhibitors of dual-specific tyrosine phosphorylation-regulated kinase 1A (DYRK1A) for the treatment of Alzheimer’s disease (AD);Bioorganic & Medicinal Chemistry;2024-09

2. Dual targeting of inflammation and β-cell dysfunction for therapy of diabetes mellitus;Journal of Drug Delivery Science and Technology;2024-08

3. Novel 6-hydroxybenzothiazol-2-carboxamides as potent and selective monoamine oxidase B inhibitors endowed with neuroprotective activity;European Journal of Medicinal Chemistry;2024-04

4. EGCG-like non-competitive inhibitor of DYRK1A rescues cognitive defect in a down syndrome model;European Journal of Medicinal Chemistry;2024-02

5. Originally Designed Dyrk1a Inhibitors as Potent Dyrk1a/Clk1/Clk4/Haspin Multiple Inhibitors: Synthesis and Biological Activities of Sulfur-Containing Tetracycles;2024